Tesamorelin is a synthetic 44-amino-acid GHRH analogue with an N-terminal trans-3-hexenoyl modification. It is discussed in literature around GHRH receptor activity, endocrine marker models, peptide stability, and structure-function comparison.
The useful distinction is that Tesamorelin is a GHRH analogue, not a ghrelin receptor secretagogue. Customers often compare it with Sermorelin, CJC-1295 no-DAC, and modified GRF(1-29) to understand how sequence length and structural modification change pathway behaviour.
This product is a strong fit for GHRH receptor pathway work and GH/IGF-1-associated marker models. The specification table covers the long sequence, formula, molecular mass, purity, solubility, and storage details.
The references below are starting points for the mechanisms discussed here. The specification table on this page covers identity, formula, molecular mass, physical form, solubility, storage, and lot-level analytical information.
References
Research-use notice: Supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use.
